WallStSmart
AGL

agilon health Inc

NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES

$27.89
-0.04% today

Updated 2026-04-29

Market cap
$464.64M
P/E ratio
P/S ratio
0.08x
EPS (TTM)
$-24.50
Dividend yield
52W range
$7 – $120
Volume
3.3M

agilon health Inc (AGL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-79.6%
Last 4 quarters
Revenue YoY growth
+3.1%
Most recent quarter
EPS YoY growth
-43.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+13.5%
2026-03-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$-0.36-31.7%$0.62$0.70+13.5%
2025-11-04$-0.27-80.0%$0.81$0.75-7.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.27$-0.36-31.7%$1.57B+3.1%
2025-09-30$-0.15$-0.27-80.0%$1.44B-1.1%
2025-06-30$-0.11$-0.25-127.3%$1.39B-5.9%
2025-03-31$0.01$-0.01-173.7%$1.53B-4.5%
2024-12-31$-0.13$-0.25-95.3%$1.52B+86.7%
2024-09-30$-0.11$-0.29-163.6%$1.45B+27.6%
2024-06-30$-0.08$-0.07+12.5%$1.48B+38.7%
2024-03-31$-0.01$-0.01+0.0%$1.60B+52.2%
2023-12-31$-0.30$-0.41-36.7%$815.50M
2023-09-30$-0.06$-0.08-33.3%$1.14B
2023-06-30$-0.03$-0.04-33.3%$1.07B
2023-03-31$0.02$0.04+100.0%$1.05B

Frequently asked questions

Has agilon health Inc beaten earnings estimates?
agilon health Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -79.6% over the last 3 quarters.
How does AGL stock react to earnings?
AGL stock has moved an average of +3.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is agilon health Inc's revenue growth rate?
agilon health Inc reported year-over-year revenue growth of +3.1% in its most recent quarter, with EPS growing -43.2% year-over-year.